Scientists still are not sure how neurological symptoms arise in COVID-19. Is it because SARS-CoV-2 infects the brain? Or are these symptoms the result of inflammation in the rest of the body? 1/
Headaches, memory problems, and fatigue are just some of the neurological impacts that arise during coronavirus infection and can last well beyond the acute period. Even early on in the pandemic, researchers surmised that direct infection of the brain could be the cause. 2/
Researchers took that as their hypothesis at the start, too. But so far, there has been no clear evidence that the coronavirus can persist in the brain, let alone proliferate. 3/
For that, we would have needed to find evidence of intact virus particles in the brain, for example. Instead, the indications that the coronavirus could infect the brain come from indirect testing methods, so they aren't entirely conclusive. 4/
According to a second hypothesis, the neurological symptoms would instead be a kind of side effect of the strong immune response the body deploys to defend against the virus. 5/
In a new study, the researchers analyzed various areas of the brain in 21 people who died in hospital settings, typically in an ICU, due to severe coronavirus infection. For comparison, they studied nine patients who died of other causes after treatment in ICU. 6/
First, they looked to see whether the tissue showed any visible changes and hunted for any indication of coronavirus. Then they conducted a detailed analysis of genes and proteins to identify the specific processes that had taken place inside individual cells. 7/
The researchers found coronavirus genetic material in the brain in some cases. But they didn't find neurones infected with SARS-CoV-2 8/
They assume that immune cells absorbed the virus in the body and then traveled to the brain. They're still carrying the virus, but it doesn't infect cells of the brain. So coronavirus has invaded other cells in the body, but not the brain itself. 9/
Still, the researchers did note striking changes in molecular processes in some cells of the brain in those infected with COVID-19: For example, the cells ramped up the interferon signaling pathway, which is typically activated in the course of a viral infection. 10/
Some neurons evidently react to the inflammation in the rest of the body. This molecular reaction could be a good explanation for the neurological symptoms we see in COVID-19 patients. 11/
For example, neurotransmitters emitted by these cells in the brainstem could cause fatigue. That's because the brainstem is home to groups of cells that control drive, motivation, and mood. 12/
The reactive nerve cells were found primarily in what are known as the nuclei of the vagus nerve. These are nerve cells located in the brainstem that extend all the way to organs such as the lungs, intestine, and heart. 13/
In simplified terms, the vagus nerve ‘senses' the inflammatory response in different organs of the body and reacts to it in the brainstem—without there being any actual infection of brain tissue. 14/
Through this mechanism, the inflammation does spread from the body to the brain in a way, which can disrupt brain function. 15/
The neurons' reaction to the inflammation is temporary, as shown by a comparison of people who died during an acute coronavirus infection with those who died at least two weeks afterward. 16/
The molecular changes are most evident during the acute infection phase, but they do normalize again afterward—at least in the vast majority of cases. 17/
They further state that it's possible that if the inflammation becomes chronic, that could be what causes the neurological symptoms often observed in #longCOVID in some people. 18/
To follow up on this suspicion, the team of researchers is now planning to study the molecular signatures in the cerebral fluid of long COVID patients in greater detail. 19/
Conclusion:
The data indicate that even without persistence of SARS-CoV-2 in the CNS, local immune reactions are prevailing, potentially causing functional disturbances that contribute to neurological complications of COVID-19 20/20
A new research found that the occurrences of respiratory disorders among patients who survived for 30 days after the #COVID19 diagnosis continued to rise consistently, including asthma, bronchiectasis, COPD, ILD, PVD, and lung cancer. 1/
Besides, during the 24-months follow-up, researchers observed an increasing trend in the risks of asthma and bronchiectasis over time, which indicates that long-term monitoring and meticulous follow-up of these patients is essential. 2/
Reinfection with COVID-19 led to a greater risk of developing asthma, COPD, lung diseases, and lung cancer compared to those with a single infection.
Additionally, most risks of respiratory outcomes were increased before the availability of COVID-19 vaccination. 3/
Serial infections of WT-SARS-2 in mice yield mouse-adapted strains w/ greater infectivity & mortality.
Researchers investigated if passaging unmodified Beta & Delta 20 times in K18-ACE2 mice drives human health-relevant evolution & if evolution is lineage-dependent. 1/
Late-passage virus causes more severe disease, at organism & lung tissue scales, with late-passage Delta demonstrating antibody resistance and interferon suppression. 2/
This resistance co-occurs with a de novo spike S371F mutation, linked with both traits. S371F, an Omicron-characteristic mutation is co-inherited at times with spike E1182G existing in different within-sample viral variants at others. 3/
IV injections of SARS-CoV-2 spike-protein were administered to transgenic mice and 7 days later, middle cerebral artery/FeCl3 thromboembolic was induced in both the spike-protein-injected and control mice. 1/
Laser imaging revealed that administration of SARS-CoV-2 spike-protein caused a significant increase in the time required for vascular recanalization in the mice. 2/
Additionally, the spike-protein-injected mice showed significant increase in infarct size, along with decreased vascular density and increased vascular rarefaction, as compared to control mice. 3/
SARS-CoV-2 can cause several autoimmune & autoinflammatory disorders.
Both illnesses cause immune-mediated tissue damage, the immunological reaction is followed by an increase in inflammatory cytokine release, & both illnesses are treatable w/ immunomodulatory medications. 1/
Patients who suffer from certain autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and others, are more likely to develop SARS-CoV-2 infection, either because the autoimmune disease is active or because of the medications used to treat it. 2/
On the other hand, autoimmune disorders can also be brought on by SARS-CoV-2 infection.
Autoimmune illnesses are chronic multifactorial disorders. 3/
A new study identified elevated serological responses to SARS-CoV-2 in severe #LongCOVID suggestive of chronic antigen stimulation.
The key finding of the study: “SARS-CoV-2 specific CD8+ T cells were less expanded in LongCOVID cases” 1/
Persistent viral reservoirs proposed in LongCOVID & using multiple orthogonal methods, researchers identify a subset of patients with detectable antigens, but with minimal overlap across assays, and no correlation to symptoms or immune measurements. 2/
Elevated serologic responses to SARS-CoV-2 on the other hand were inversely correlated with clonally expanded memory CD8+ T cells, indicating that restrained clonal expansion enables viral persistence, chronic antigen exposure & elevated IgG responses. 3/
Now, a new, cellular level study has also proved that!
The study finds that altered mitochondrial respiration in peripheral blood mononuclear cells of LongCovid patients may be contributing to the etiology of PASC. 1/
The pathomechanisms and cellular aspects of #LongCovid (PASC) are also not entirely understood. PASC has been theorized to result from damaged tissue, inflammation, thrombosis, or autoreactive B and T cells. 2/
Additionally, reservoirs of SARS-2 in tissues & immune dysregulation have been proposed as causes
One particular concern is the role of mitochondrial function or dysfunction in LongCovid (PASC). Mitochondrial dysfunction has been described in acute severe SARS2 infection. 3/